HPLC columns, 3/13:76
Thermo Fisher Scientific’s Syncronis high-performance liquid chromatography columns are now available with 3-mm particle size. The new size complements the existing 1.7- and 5-µm particle sizes.
Webinars and Sponsored Roundtables — Register Now
Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.
Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 10, 2026, 1 PM-2 PM ET
Join us for a session to help improve diagnostic accuracy in your practice when scoring HER2 IHC 0 with faint, incomplete membrane staining in ≤10% of tumor cells vs IHC 0 with no membrane staining detected in patients with mBC.
Webinar presenter Jeffrey Gregg, MD, University of Nevada
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace Directory
Horizon Discovery named ‘most promising’ at conference, 3/13:76
Horizon Discovery was named the most promising company at the Personalized Medicine World Conference 2013. Horizon was chosen from 32 shortlisted companies based on technology, historical performance of the company, and forward business plans.
Yellow HRP stain, 3/13:76
Diagnostic BioSystems’ PermaYellow/horseradish peroxidase (HRP) is a substrate-chromogen system designed for immunohistochemistry or in situ hybridization when using horseradish peroxidase. PermaYellow/HRP produces a distinct bright yellow color that can be distinguished easily from other stains.
Liquid-handling extraction products, 3/13:76
Akonni Biosystems has extended its family of smart-tip extraction products for rapidly purifying human genomic deoxyribonucleic acid (gDNA) on Hamilton’s Microlab Star robotic liquid-handling workstations.
Five percent oxalic acid, 3/13:76
Used in conjunction with Alpha-Tec Systems’ NAC-PAC (N-acetylcysteinepackage ) line of digestion/ decontamination, buffering, and resuspension reagents, Alpha-Tec’s five percent oxalic acid is recommended to optimize decontamination conditions of specimens with P. aeruginosa.
Dako, Lilly to collaborate, 3/13:76
Dako, an Agilent Technologies company, has entered into a master framework agreement with Eli Lilly and Company for the development of companion diagnostic tests to identify patients who may be more likely to benefit from an investigational oncology medicine currently under development by Lilly.
Mycology reference guide, 3/13
Mycology Benchtop Reference Guide is an illustrated guide to common fungi. Included are full-color colony and microscopic views. The guide provides a convenient way for students and medical technologists to quickly and confidently identify fungi.
Qiagen adds biomarkers for personalized health care, 3/13:75
Qiagen announced three separate agreements that add biomarkers to its diagnostic pipeline for personalized health care applications to guide treatments with various medicines based on a patient’s genomic information.
PerkinElmer, Verinata to expand access to prenatal test, 3/13:75
PerkinElmer and Verinata Health announced a strategic agreement for expanding access to Verinata’s Verifi test, a comprehensive noninvasive prenatal test (NIPT) for high-risk pregnancies. The Verifi test, performed at Verinata’s CLIA-certified California laboratory, uses a single maternal blood draw at as early as 10 weeks of pregnancy to detect multiple fetal chromosomal aneuploidies. Under terms of the collaboration, PerkinElmer will serve as an exclusive Verinata partner in joint sales and marketing of the Verifi test.
RA biomarker, 3/13:75
Leiden University Medical Center and Inova Diagnostics have completed a worldwide license agreement for technology developed at LUMC to detect antibodies to carbamylated proteins (anti-CarP). This technology represents an important advance in diagnosing rheumatoid arthritis (RA).